Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics.

Petra BrhlikovaAashna MehtaPatricia McGettiganAllyson M PollockPeter RoderickHabib Hasan Farooqui

Published in: Journal of pharmaceutical policy and practice (2023)

The initiatives had limited impact. Regulatory enforcement has been slow and weak, with many unapproved, and even banned, FDCs remaining on the market.

Keyphrases

transcription factor
health insurance
drug induced